Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1722929
Xiumin Qin, Feihong Yu, Hui Guo, Chunna Zhao, Jie Wu
Objective: This study aimed to summarize the clinical experience of Endoscopic Retrograde Cholangiopancreatography (ERCP) in a pediatric population, analyzing the disease spectrum, procedural characteristics, and clinical outcomes to contribute to the understanding of its application in children.
Methods: This study reviewed the clinical data of children who presented to our hospital and underwent ERCP and related procedures between January 2021 and December 2024. Collected data encompassed patient demographics, specific disease indications, detailed endoscopic techniques employed, procedural success rates, and the incidence and management of related complications.
Results: The study cohort had a mean age of 8.31 ± 3.63 years. The primary indication for ERCP was pancreatic disease, accounting for 72% (134/186) of procedures. These included chronic pancreatitis (n = 75), pancreatic trauma (n = 17), and acute pancreatitis with pseudocysts (n = 17). Biliary diseases constituted 28% (52/186), mainly choledocholithiasis (n = 33) and pancreatobiliary maljunction (n = 9). Commonly performed endoscopic interventions were pancreatic duct stent placement (n = 95), biliary stent placement (n = 50), and stone extraction from both ducts (n = 70 and 33, respectively). The overall procedural success rate was 90.5% (171/186). A significant difference was noted when stratified by operation time: procedures completed within 60 min had a 96.7% (115/119) success rate, compared to 80.0% (56/70) for those lasting 60 min or longer (P < 0.001). Post-procedure complications were recorded in 11 cases (5.9%), including post-pancreatitis (n = 6), infection (n = 4), and gastrointestinal bleeding (n = 1).All complications were all resolved with conservative medical management.
Conclusion: This study confirms that pancreatic diseases (accounting for 72%) are the main indication. Endoscopic Retrograde Cholangiopancreatography (ERCP) has a high success rate (90.5%) in the diagnosis and treatment of biliary and pancreatic diseases in children. However, prolonged procedure time (>60 min) significantly reduces the success rate.
{"title":"Application of ERCP in biliary and pancreatic diseases in children: a retrospective analysis of 4-year clinical data from a single center.","authors":"Xiumin Qin, Feihong Yu, Hui Guo, Chunna Zhao, Jie Wu","doi":"10.3389/fped.2025.1722929","DOIUrl":"10.3389/fped.2025.1722929","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to summarize the clinical experience of Endoscopic Retrograde Cholangiopancreatography (ERCP) in a pediatric population, analyzing the disease spectrum, procedural characteristics, and clinical outcomes to contribute to the understanding of its application in children.</p><p><strong>Methods: </strong>This study reviewed the clinical data of children who presented to our hospital and underwent ERCP and related procedures between January 2021 and December 2024. Collected data encompassed patient demographics, specific disease indications, detailed endoscopic techniques employed, procedural success rates, and the incidence and management of related complications.</p><p><strong>Results: </strong>The study cohort had a mean age of 8.31 ± 3.63 years. The primary indication for ERCP was pancreatic disease, accounting for 72% (134/186) of procedures. These included chronic pancreatitis (<i>n</i> = 75), pancreatic trauma (<i>n</i> = 17), and acute pancreatitis with pseudocysts (<i>n</i> = 17). Biliary diseases constituted 28% (52/186), mainly choledocholithiasis (<i>n</i> = 33) and pancreatobiliary maljunction (<i>n</i> = 9). Commonly performed endoscopic interventions were pancreatic duct stent placement (<i>n</i> = 95), biliary stent placement (<i>n</i> = 50), and stone extraction from both ducts (<i>n</i> = 70 and 33, respectively). The overall procedural success rate was 90.5% (171/186). A significant difference was noted when stratified by operation time: procedures completed within 60 min had a 96.7% (115/119) success rate, compared to 80.0% (56/70) for those lasting 60 min or longer (<i>P</i> < 0.001). Post-procedure complications were recorded in 11 cases (5.9%), including post-pancreatitis (<i>n</i> = 6), infection (<i>n</i> = 4), and gastrointestinal bleeding (<i>n</i> = 1).All complications were all resolved with conservative medical management.</p><p><strong>Conclusion: </strong>This study confirms that pancreatic diseases (accounting for 72%) are the main indication. Endoscopic Retrograde Cholangiopancreatography (ERCP) has a high success rate (90.5%) in the diagnosis and treatment of biliary and pancreatic diseases in children. However, prolonged procedure time (>60 min) significantly reduces the success rate.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1722929"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1720645
Nienke H van Dokkum, Arend F Bos, Sijmen A Reijneveld, Elianne J L E Vrijlandt
Aim: We seek to elucidate the prevalence, types of respiratory symptoms experienced, and potential early-life risk factors of asthma in adolescence.
Methods: We performed a prospective cohort study including 294 adolescents [130 moderately-late preterm (MLP), 81 early preterm (EP), and 83 full-term (FT)]. Asthma, asthma-like symptoms, and smoking in early childhood and adolescence were self-reported. We collected prenatal and postnatal characteristics, including maternal smoking, bronchopulmonary dysplasia, and respiratory syncytial virus (RSV) infections.
Results: In 11% of EP, 4% of MLP, and 4% of FT adolescents, a formal asthma diagnosis was made. Asthma-like symptoms were reported in 14%, 14%, and 7% of the cases, respectively. Being hospitalized for an RSV infection was associated with a four times higher risk of asthma in adolescence (odds ratio 3.68 and 95% confidence interval 1.04-13.0), while other predictors did not contribute.
Conclusion: MLP adolescents have similar rates of asthma and asthma-like symptoms as their FT peers, while EP adolescents might have a higher risk of asthma but have similar rates of asthma-like symptoms. RSV infections that require hospitalization are associated with an asthma diagnosis in adolescence.
{"title":"Prevalence and early-life risk factors of asthma in preterm adolescents: a cohort study.","authors":"Nienke H van Dokkum, Arend F Bos, Sijmen A Reijneveld, Elianne J L E Vrijlandt","doi":"10.3389/fped.2025.1720645","DOIUrl":"10.3389/fped.2025.1720645","url":null,"abstract":"<p><strong>Aim: </strong>We seek to elucidate the prevalence, types of respiratory symptoms experienced, and potential early-life risk factors of asthma in adolescence.</p><p><strong>Methods: </strong>We performed a prospective cohort study including 294 adolescents [130 moderately-late preterm (MLP), 81 early preterm (EP), and 83 full-term (FT)]. Asthma, asthma-like symptoms, and smoking in early childhood and adolescence were self-reported. We collected prenatal and postnatal characteristics, including maternal smoking, bronchopulmonary dysplasia, and respiratory syncytial virus (RSV) infections.</p><p><strong>Results: </strong>In 11% of EP, 4% of MLP, and 4% of FT adolescents, a formal asthma diagnosis was made. Asthma-like symptoms were reported in 14%, 14%, and 7% of the cases, respectively. Being hospitalized for an RSV infection was associated with a four times higher risk of asthma in adolescence (odds ratio 3.68 and 95% confidence interval 1.04-13.0), while other predictors did not contribute.</p><p><strong>Conclusion: </strong>MLP adolescents have similar rates of asthma and asthma-like symptoms as their FT peers, while EP adolescents might have a higher risk of asthma but have similar rates of asthma-like symptoms. RSV infections that require hospitalization are associated with an asthma diagnosis in adolescence.</p><p><strong>Clinical trial registration: </strong>https://www.controlled-trials.com, identifier ISRCTN 80622320.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1720645"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847436/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1703027
Pei Tao, Zhigang Wang, Kaiyu Zhou, Ying Wu
Objectives: To describe the clinical characteristics, management, and outcomes of children with Mycoplasma pneumoniae pneumonia (MPP) complicated by pulmonary embolism (PE).
Methods: We conducted a retrospective review of eight children diagnosed with Mycoplasma pneumoniae pneumonia complicated by pulmonary embolism between January 2023 and December 2024 at our hospital. The diagnosis of pulmonary embolism was confirmed by computed tomography pulmonary angiography (CTPA). Demographic characteristics, clinical manifestations, laboratory findings, imaging features, treatment strategies, and outcomes were systematically collected.
Results: The cohort included six males and two females, with a mean age of 7.81 ± 3.64 years. The median interval from pneumonia onset to PE diagnosis was 14 days. All patients had severe or refractory MPP. Common symptoms included chest pain (n = 6), hemoptysis (n = 4), and dyspnea (n = 2). CTPA demonstrated pulmonary arterial filling defects in all cases. All patients received anticoagulation therapy with low-molecular-weight heparin followed by rivaroxaban, resulting in favorable clinical outcomes. During 3-6 months of follow-up, complete resolution of emboli was observed, thrombophilia-related laboratory abnormalities normalized, and no recurrence occurred.
Conclusions: Early diagnosis and timely anticoagulation are crucial for favorable outcomes in children with MPP-related PE. Although the small sample size limits generalizability, this case series provides a structured clinical dataset that captures demographic, laboratory, immunological, and imaging features. These data may serve as a reference for future studies aiming to better understand host susceptibility and immunothrombotic mechanisms in pediatric PE.
{"title":"Pulmonary embolism complicating <i>Mycoplasma pneumoniae</i> pneumonia in children: a retrospective case series.","authors":"Pei Tao, Zhigang Wang, Kaiyu Zhou, Ying Wu","doi":"10.3389/fped.2025.1703027","DOIUrl":"10.3389/fped.2025.1703027","url":null,"abstract":"<p><strong>Objectives: </strong>To describe the clinical characteristics, management, and outcomes of children with <i>Mycoplasma pneumoniae</i> pneumonia (MPP) complicated by pulmonary embolism (PE).</p><p><strong>Methods: </strong>We conducted a retrospective review of eight children diagnosed with <i>Mycoplasma pneumoniae</i> pneumonia complicated by pulmonary embolism between January 2023 and December 2024 at our hospital. The diagnosis of pulmonary embolism was confirmed by computed tomography pulmonary angiography (CTPA). Demographic characteristics, clinical manifestations, laboratory findings, imaging features, treatment strategies, and outcomes were systematically collected.</p><p><strong>Results: </strong>The cohort included six males and two females, with a mean age of 7.81 ± 3.64 years. The median interval from pneumonia onset to PE diagnosis was 14 days. All patients had severe or refractory MPP. Common symptoms included chest pain (<i>n</i> = 6), hemoptysis (<i>n</i> = 4), and dyspnea (<i>n</i> = 2). CTPA demonstrated pulmonary arterial filling defects in all cases. All patients received anticoagulation therapy with low-molecular-weight heparin followed by rivaroxaban, resulting in favorable clinical outcomes. During 3-6 months of follow-up, complete resolution of emboli was observed, thrombophilia-related laboratory abnormalities normalized, and no recurrence occurred.</p><p><strong>Conclusions: </strong>Early diagnosis and timely anticoagulation are crucial for favorable outcomes in children with MPP-related PE. Although the small sample size limits generalizability, this case series provides a structured clinical dataset that captures demographic, laboratory, immunological, and imaging features. These data may serve as a reference for future studies aiming to better understand host susceptibility and immunothrombotic mechanisms in pediatric PE.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1703027"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1710240
Jocelyn Brown, Talea Cornelius, Gabriella Farland, Philip Gialopsos, Rita Charon
Introduction: Art and humanities-based approaches have been incorporated in Diversity, Equity and Inclusion (DEI) training and anti-bias curriculum to address structural racism and personal biases via reflection. Research has shown that the use of visual art or texts via narrative medicine workshops results in improved communication with patients and colleagues and increased commitment to interrupting bias.
Methods: Using members of a hospital-based Child Abuse Bias Mitigating Task Force, this study tests the hypothesis that narrative medicine workshops provide a space where conversations of race and bias in the context of child abuse evaluations can take place.
Results: Workshops participants noted the unique group experience that, through sharing and communal support, helped build compassion, function more effectively as a team, and even find confidence in their own voice. Intertwined with the ability to connect with and support each other as a team was the common thread of understanding differences in perspectives and personal histories. Most participants agree that the workshops increased their ease in having conversations about privilege and bias in clinical assessment.
Conclusion: We conclude that the use of art and creativity allows for personal and structural insights on racism and social advocacy with significant promise for reducing bias in child abuse evaluations.
{"title":"An exploratory study of addressing bias for child abuse teams: the role of narrative medicine.","authors":"Jocelyn Brown, Talea Cornelius, Gabriella Farland, Philip Gialopsos, Rita Charon","doi":"10.3389/fped.2025.1710240","DOIUrl":"10.3389/fped.2025.1710240","url":null,"abstract":"<p><strong>Introduction: </strong>Art and humanities-based approaches have been incorporated in Diversity, Equity and Inclusion (DEI) training and anti-bias curriculum to address structural racism and personal biases via reflection. Research has shown that the use of visual art or texts via narrative medicine workshops results in improved communication with patients and colleagues and increased commitment to interrupting bias.</p><p><strong>Methods: </strong>Using members of a hospital-based Child Abuse Bias Mitigating Task Force, this study tests the hypothesis that narrative medicine workshops provide a space where conversations of race and bias in the context of child abuse evaluations can take place.</p><p><strong>Results: </strong>Workshops participants noted the unique group experience that, through sharing and communal support, helped build compassion, function more effectively as a team, and even find confidence in their own voice. Intertwined with the ability to connect with and support each other as a team was the common thread of understanding differences in perspectives and personal histories. Most participants agree that the workshops increased their ease in having conversations about privilege and bias in clinical assessment.</p><p><strong>Conclusion: </strong>We conclude that the use of art and creativity allows for personal and structural insights on racism and social advocacy with significant promise for reducing bias in child abuse evaluations.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1710240"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1641407
N Kh Gabitova, I N Cherezova, I V Osipova, D I Sadykova, Dalal Nasr, Ayman A Gobarah, Ahmed Arafat
Neuroblastoma is the most prevalent extracranial solid tumor in infancy and early childhood, accounting for 8%-10% of all pediatric malignancies and contributing significantly to cancer-related mortality. Its clinical spectrum ranges from spontaneous regression to aggressive metastatic disease, often influenced by underlying genetic aberrations such as MYCN amplification and chromosomal deletions (1p, 11q, and 17q). We present a rare case of a full-term male neonate diagnosed with stage 4 neuroblastoma originating from the left adrenal gland, exhibiting both MYCN amplification and 1p deletion. The patient had extensive liver metastases and supradiaphragmatic lymphadenopathy at diagnosis. Multimodal treatment, including intensive chemotherapy per the NB2004 protocol, surgical resection, high-dose consolidation chemotherapy, and autologous hematopoietic stem cell transplantation (AHSCT), led to complete remission by 11 months of age. Despite severe post-transplant complications such as sepsis and enteropathy, the patient remained disease-free with normal developmental milestones at follow-up. To the best of our knowledge, this is the first reported case of neonatal neuroblastoma with concurrent MYCN amplification and 1p deletion achieving favorable outcome through comprehensive multimodal therapy. This case underscores the importance of early diagnosis, genetic profiling, and aggressive treatment in managing high-risk neuroblastoma in neonates.
{"title":"Case Report: Complete remission in a neonate with high-risk neuroblastoma harboring MYCN amplification and 1p deletion: a case for aggressive early intervention, and literature review.","authors":"N Kh Gabitova, I N Cherezova, I V Osipova, D I Sadykova, Dalal Nasr, Ayman A Gobarah, Ahmed Arafat","doi":"10.3389/fped.2025.1641407","DOIUrl":"10.3389/fped.2025.1641407","url":null,"abstract":"<p><p>Neuroblastoma is the most prevalent extracranial solid tumor in infancy and early childhood, accounting for 8%-10% of all pediatric malignancies and contributing significantly to cancer-related mortality. Its clinical spectrum ranges from spontaneous regression to aggressive metastatic disease, often influenced by underlying genetic aberrations such as MYCN amplification and chromosomal deletions (1p, 11q, and 17q). We present a rare case of a full-term male neonate diagnosed with stage 4 neuroblastoma originating from the left adrenal gland, exhibiting both MYCN amplification and 1p deletion. The patient had extensive liver metastases and supradiaphragmatic lymphadenopathy at diagnosis. Multimodal treatment, including intensive chemotherapy per the NB2004 protocol, surgical resection, high-dose consolidation chemotherapy, and autologous hematopoietic stem cell transplantation (AHSCT), led to complete remission by 11 months of age. Despite severe post-transplant complications such as sepsis and enteropathy, the patient remained disease-free with normal developmental milestones at follow-up. To the best of our knowledge, this is the first reported case of neonatal neuroblastoma with concurrent MYCN amplification and 1p deletion achieving favorable outcome through comprehensive multimodal therapy. This case underscores the importance of early diagnosis, genetic profiling, and aggressive treatment in managing high-risk neuroblastoma in neonates.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1641407"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1689213
Tianhe Ye, Cong Liu
Background: Pulmonary artery sling (PAS) is a rare congenital vascular anomaly in which the left pulmonary artery (LPA) originates from the right pulmonary artery (RPA), forming a ring around the tracheobronchial tree. Due to non-specific respiratory symptoms, it is frequently misdiagnosed, leading to significant delays in diagnosis. This report emphasizes the crucial role of quantitative multimodal imaging in establishing a definitive diagnosis, stratifying risk, and guiding optimal surgical planning.
Case presentation: A 4-year-and-7-month-old boy presented with a 4-year history of recurrent cough and wheezing that was refractory to standard medical therapy. Echocardiography revealed a dilated main pulmonary artery (MPA) measuring 1.9 cm (Z-score +3.2) and an anomalous origin of the LPA from the RPA, with an elevated peak flow velocity of 1.75 m/s. Contrast-enhanced computed tomography angiography (CTA) subsequently confirmed a Type I PAS, enabling precise quantification of a severe focal stenosis of the LPA (minimal diameter 2.8 mm) and demonstrating the absence of significant intrinsic tracheobronchial stenosis. Based on these findings, the patient underwent successful reimplantation of the LPA onto the MPA with an autologous pericardial patch. The postoperative course was uneventful, with complete resolution of respiratory symptoms, and follow-up imaging confirmed a patent anastomosis with successful hemodynamic outcomes.
Conclusions: This case of isolated PAS underscores the indispensable role of a multimodal imaging strategy. While echocardiography can provide initial clues, quantitative CTA is paramount for definitive anatomical classification, precise stenosis quantification, and comprehensive preoperative planning. Early consideration of PAS in children presenting with refractory respiratory symptoms, coupled with advanced imaging, can prevent misdiagnosis and optimize outcomes.
背景:肺动脉悬吊(Pulmonary artery sling, PAS)是一种罕见的先天性血管异常,其中左肺动脉(LPA)起源于右肺动脉(RPA),在气管支气管树周围形成一个环。由于非特异性呼吸道症状,它经常被误诊,导致诊断严重延误。本报告强调了定量多模态成像在建立明确诊断、风险分层和指导最佳手术计划方面的关键作用。病例介绍:一名4岁7个月大的男孩,有4年的复发性咳嗽和喘息史,对标准药物治疗无效。超声心动图显示肺动脉主动脉(MPA)扩张1.9 cm (Z-score +3.2), LPA与RPA的起点异常,峰值血流速度升高1.75 m/s。对比增强计算机断层血管造影(CTA)随后证实了I型PAS,能够精确量化LPA严重局灶性狭窄(最小直径2.8 mm),并证明没有明显的内在气管支气管狭窄。基于这些发现,患者成功地用自体心包补片将LPA移植到MPA上。术后过程顺利,呼吸症状完全缓解,随访影像学证实吻合通畅,血流动力学结果成功。结论:这个孤立性PAS病例强调了多模式成像策略不可或缺的作用。虽然超声心动图可以提供初步线索,但定量CTA对于明确的解剖分类、精确的狭窄量化和全面的术前计划至关重要。在出现难治性呼吸道症状的儿童中,早期考虑PAS,再加上先进的影像学检查,可以防止误诊并优化结果。
{"title":"Case Report: Quantitative multimodal imaging for surgical planning in isolated pulmonary artery sling.","authors":"Tianhe Ye, Cong Liu","doi":"10.3389/fped.2025.1689213","DOIUrl":"10.3389/fped.2025.1689213","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary artery sling (PAS) is a rare congenital vascular anomaly in which the left pulmonary artery (LPA) originates from the right pulmonary artery (RPA), forming a ring around the tracheobronchial tree. Due to non-specific respiratory symptoms, it is frequently misdiagnosed, leading to significant delays in diagnosis. This report emphasizes the crucial role of quantitative multimodal imaging in establishing a definitive diagnosis, stratifying risk, and guiding optimal surgical planning.</p><p><strong>Case presentation: </strong>A 4-year-and-7-month-old boy presented with a 4-year history of recurrent cough and wheezing that was refractory to standard medical therapy. Echocardiography revealed a dilated main pulmonary artery (MPA) measuring 1.9 cm (<i>Z</i>-score +3.2) and an anomalous origin of the LPA from the RPA, with an elevated peak flow velocity of 1.75 m/s. Contrast-enhanced computed tomography angiography (CTA) subsequently confirmed a Type I PAS, enabling precise quantification of a severe focal stenosis of the LPA (minimal diameter 2.8 mm) and demonstrating the absence of significant intrinsic tracheobronchial stenosis. Based on these findings, the patient underwent successful reimplantation of the LPA onto the MPA with an autologous pericardial patch. The postoperative course was uneventful, with complete resolution of respiratory symptoms, and follow-up imaging confirmed a patent anastomosis with successful hemodynamic outcomes.</p><p><strong>Conclusions: </strong>This case of isolated PAS underscores the indispensable role of a multimodal imaging strategy. While echocardiography can provide initial clues, quantitative CTA is paramount for definitive anatomical classification, precise stenosis quantification, and comprehensive preoperative planning. Early consideration of PAS in children presenting with refractory respiratory symptoms, coupled with advanced imaging, can prevent misdiagnosis and optimize outcomes.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1689213"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is a rare autosomal connective tissue disorder characterized by progressive kyphoscoliosis, congenital muscular hypotonia, marked joint hypermobility, and severe skin hyperextensibility and fragility. Deficiency of lysyl hydroxylase due to variants of the PLOD1 gene has been identified as a pathogenic cause of the disease. Vascular fragility in kEDS has rarely been reported. Here, we report a 15-year-old Chinese boy with kEDS-PLOD1 who presented with a superior mesenteric aneurysm and severe vascular complications. The patient underwent emergency hybrid surgery combining hemostasis by laparotomy and stent graft placement superior to the bleeding artery by endovascular intervention. The patient's presentation improved postoperatively. Unfortunately, the patient died despite medical intervention. Whole exome sequencing identified compound heterozygous variants in the patient's PLOD1 gene: a reported variant, c.1095C > T, and a novel variant, c.1262delC. The c.1262delC variant is a frameshift variant that results in a premature stop codon and loss of gene function. Overall, this case report further expands the genetic landscape of kEDS and suggests that vascular intervention in these patients requires individualized assessment of vessel function and local perfusion status.
{"title":"Kyphoscoliotic Ehlers-Danlos syndrome associated with superior mesenteric artery aneurysm and abdominal aortic rupture: a case report.","authors":"Jiru Li, Keqiang Liu, Xiaodong Zhu, Yaya Xu, Lili Xu, Runmin Chi, Yueniu Zhu","doi":"10.3389/fped.2025.1737724","DOIUrl":"10.3389/fped.2025.1737724","url":null,"abstract":"<p><p>Kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is a rare autosomal connective tissue disorder characterized by progressive kyphoscoliosis, congenital muscular hypotonia, marked joint hypermobility, and severe skin hyperextensibility and fragility. Deficiency of lysyl hydroxylase due to variants of the <i>PLOD1</i> gene has been identified as a pathogenic cause of the disease. Vascular fragility in kEDS has rarely been reported. Here, we report a 15-year-old Chinese boy with kEDS-<i>PLOD1</i> who presented with a superior mesenteric aneurysm and severe vascular complications. The patient underwent emergency hybrid surgery combining hemostasis by laparotomy and stent graft placement superior to the bleeding artery by endovascular intervention. The patient's presentation improved postoperatively. Unfortunately, the patient died despite medical intervention. Whole exome sequencing identified compound heterozygous variants in the patient's <i>PLOD1</i> gene: a reported variant, c.1095C > T, and a novel variant, c.1262delC. The c.1262delC variant is a frameshift variant that results in a premature stop codon and loss of gene function. Overall, this case report further expands the genetic landscape of kEDS and suggests that vascular intervention in these patients requires individualized assessment of vessel function and local perfusion status.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1737724"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847290/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1734531
Emel Uyar, Bilge Delibalta, Nese Ozyurt
Background: Extravasation and infiltration are preventable complications of intravenous therapy that can cause severe tissue injury in pediatric patients. Nurses play a critical role in prevention and early management, yet studies have shown that their knowledge and skills in this area are often insufficient. Simulation-based training has been shown to improve clinical competence; however, evidence specific to pediatric extravasation management is limited.
Methods: This quasi-experimental study employed a single-group pretest-posttest design. A total of 475 pediatric nurses were invited, 436 participated, and 399 were included in the final analysis after missing data excluded. A half-day, scenario-supported training program was developed by expert clinicians, combining theoretical lectures with low-fidelity, case-based simulation activities. Pre- and post-training scores were compared using nonparametric tests, with significance set at p < 0.05 and effect sizes reported. Knowledge was assessed using a validated 55-item test, and skills were measured through a four-station ObjectiveStructured Practical Examination (OSPE).
Results: Participants were predominantly female (84.7%) and held a bachelor's degree (87.5%). The majority (77.9%) had never received prior extravasation training, while 88.5% expressed a need for education. Knowledge scores improved significantly post-training (p < 0.001, r = -0.26, small effect). Skill scores showed a marked improvement (p < 0.001, r = -0.84, large effect). Subgroup analyses revealed no significant differences by gender or educational level. Nurses with 5-8 years of experience demonstrated greater knowledge gains, while those with prior training achieved higher skill improvements.
Conclusion: Scenario-supported training effectively improved pediatric nurses' competencies in extravasation and infiltration management, with the strongest effect observed in clinical skills. These findings underscore the importance of structured and repeated training, particularly for early- and mid-career nurses. Low-cost, scalable training models represent a practical and sustainable strategy to strengthen pediatric nursing practice and enhance patient safety in diverse healthcare settings.
背景:外渗和浸润是可预防的静脉治疗并发症,可导致严重的组织损伤的儿科患者。护士在预防和早期管理中发挥着关键作用,但研究表明,他们在这一领域的知识和技能往往不足。以模拟为基础的训练已被证明可以提高临床能力;然而,针对儿童外渗处理的证据有限。方法:准实验研究采用单组前测后测设计。共邀请475名儿科护士,436名参与,剔除缺失数据后最终纳入399名。专家临床医生制定了为期半天的场景支持培训计划,将理论讲座与低保真度的基于病例的模拟活动相结合。使用非参数检验比较训练前和训练后的得分,显著性设置为p。结果:参与者主要是女性(84.7%),持有学士学位(87.5%)。大多数(77.9%)从未接受过外渗培训,而88.5%表示需要接受教育。训练后知识得分显著提高(p r = -0.26,影响小)。技能得分有显著提高(p r = -0.84,效果显著)。亚组分析显示,性别和教育水平之间没有显著差异。具有5-8年经验的护士表现出更大的知识增益,而那些先前受过培训的护士则获得了更高的技能提高。结论:场景支持培训有效提高了儿科护士的外渗管理能力,其中临床技能效果最明显。这些发现强调了结构化和重复培训的重要性,特别是对职业生涯早期和中期的护士。低成本、可扩展的培训模式代表了一种实用和可持续的战略,以加强儿科护理实践,并在不同的医疗保健环境中提高患者安全。
{"title":"Effect of scenario-supported training on pediatric nurses' knowledge and skills in extravasation and infiltration management.","authors":"Emel Uyar, Bilge Delibalta, Nese Ozyurt","doi":"10.3389/fped.2025.1734531","DOIUrl":"10.3389/fped.2025.1734531","url":null,"abstract":"<p><strong>Background: </strong>Extravasation and infiltration are preventable complications of intravenous therapy that can cause severe tissue injury in pediatric patients. Nurses play a critical role in prevention and early management, yet studies have shown that their knowledge and skills in this area are often insufficient. Simulation-based training has been shown to improve clinical competence; however, evidence specific to pediatric extravasation management is limited.</p><p><strong>Methods: </strong>This quasi-experimental study employed a single-group pretest-posttest design. A total of 475 pediatric nurses were invited, 436 participated, and 399 were included in the final analysis after missing data excluded. A half-day, scenario-supported training program was developed by expert clinicians, combining theoretical lectures with low-fidelity, case-based simulation activities. Pre- and post-training scores were compared using nonparametric tests, with significance set at <i>p</i> < 0.05 and effect sizes reported. Knowledge was assessed using a validated 55-item test, and skills were measured through a four-station ObjectiveStructured Practical Examination (OSPE).</p><p><strong>Results: </strong>Participants were predominantly female (84.7%) and held a bachelor's degree (87.5%). The majority (77.9%) had never received prior extravasation training, while 88.5% expressed a need for education. Knowledge scores improved significantly post-training (<i>p</i> < 0.001, <i>r</i> = -0.26, small effect). Skill scores showed a marked improvement (<i>p</i> < 0.001, <i>r</i> = -0.84, large effect). Subgroup analyses revealed no significant differences by gender or educational level. Nurses with 5-8 years of experience demonstrated greater knowledge gains, while those with prior training achieved higher skill improvements.</p><p><strong>Conclusion: </strong>Scenario-supported training effectively improved pediatric nurses' competencies in extravasation and infiltration management, with the strongest effect observed in clinical skills. These findings underscore the importance of structured and repeated training, particularly for early- and mid-career nurses. Low-cost, scalable training models represent a practical and sustainable strategy to strengthen pediatric nursing practice and enhance patient safety in diverse healthcare settings.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1734531"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847387/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-14eCollection Date: 2025-01-01DOI: 10.3389/fped.2025.1710200
Alessio Danilo Inchingolo, Grazia Marinelli, Luisa Limongelli, Francesco Inchingolo, Gianfranco Favia, Laura Ferrante, Angela Di Noia, Cinzia Maspero, Andrea Palermo, Angelo Michele Inchingolo, Gianna Dipalma
Aim: Chronic diseases in childhood and adolescence represent a growing global challenge, with families often seeking complementary strategies beyond pharmacological treatment. This systematic review aimed to evaluate the efficacy and safety of dietary and oral supplements in pediatric chronic diseases.
Materials and methods: The review was conducted in accordance with PRISMA guidelines. A systematic search of PubMed, Scopus, Web of Science, and Cochrane Library was performed (2005-2025). Eligible studies enrolled children and adolescents (<18 years) with chronic diseases and assessed oral dietary supplements against placebo, standard care, or no intervention. Thirteen studies were included.
Results: The studies investigated autism spectrum disorder (ASD), functional gastrointestinal disorders, cystic fibrosis (CF), type 1 diabetes (T1D), bronchopulmonary dysplasia (BPD) and juvenile idiopathic arthritis. Interventions included probiotics, omega-3/6 fatty acids, vitamins, minerals, glutathione, Kre-Celazine® and Dimercaptosuccinic Acid (DMSA). Most supplements demonstrated measurable bioactivity, such as modulation of the gut microbiota, changes in inflammatory markers, or improvements in functional indices, but clinical benefits were often inconsistent or limited to subgroups. Safety was generally favorable for probiotics, polyunsaturated fatty acids, magnesium, zinc, and vitamin A, whereas DMSA chelation raised significant safety concerns.
Conclusions: Dietary and oral supplements show promise as supportive interventions in pediatric chronic diseases but cannot yet be recommended for systematic clinical use. Larger multicenter trials with longer follow-up, standardized endpoints, and predictive biomarkers are needed to identify responder subgroups and establish evidence-based recommendations.
目的:儿童和青少年慢性疾病是一个日益增长的全球性挑战,家庭往往寻求药物治疗之外的补充策略。本系统综述旨在评价膳食和口服补充剂治疗儿童慢性疾病的有效性和安全性。材料和方法:按照PRISMA指南进行审查。系统检索PubMed、Scopus、Web of Science和Cochrane Library(2005-2025)。符合条件的研究纳入了儿童和青少年(结果:这些研究调查了自闭症谱系障碍(ASD)、功能性胃肠疾病、囊性纤维化(CF)、1型糖尿病(T1D)、支气管肺发育不良(BPD)和青少年特发性关节炎。干预措施包括益生菌、omega-3/6脂肪酸、维生素、矿物质、谷胱甘肽、Kre-Celazine®和二巯基琥珀酸(DMSA)。大多数补充剂显示出可测量的生物活性,如肠道微生物群的调节、炎症标志物的改变或功能指标的改善,但临床益处往往不一致或仅限于亚组。益生菌、多不饱和脂肪酸、镁、锌和维生素A的安全性普遍有利,而DMSA螯合则引起了显著的安全性问题。结论:膳食和口服补充剂有望作为儿童慢性疾病的支持性干预措施,但尚不能推荐用于系统的临床应用。需要更大规模、随访时间更长、标准化终点和预测性生物标志物的多中心试验来确定应答亚组并建立基于证据的建议。
{"title":"Dietary and complementary oral supplements for the management of chronic diseases in children: a systematic review.","authors":"Alessio Danilo Inchingolo, Grazia Marinelli, Luisa Limongelli, Francesco Inchingolo, Gianfranco Favia, Laura Ferrante, Angela Di Noia, Cinzia Maspero, Andrea Palermo, Angelo Michele Inchingolo, Gianna Dipalma","doi":"10.3389/fped.2025.1710200","DOIUrl":"10.3389/fped.2025.1710200","url":null,"abstract":"<p><strong>Aim: </strong>Chronic diseases in childhood and adolescence represent a growing global challenge, with families often seeking complementary strategies beyond pharmacological treatment. This systematic review aimed to evaluate the efficacy and safety of dietary and oral supplements in pediatric chronic diseases.</p><p><strong>Materials and methods: </strong>The review was conducted in accordance with PRISMA guidelines. A systematic search of PubMed, Scopus, Web of Science, and Cochrane Library was performed (2005-2025). Eligible studies enrolled children and adolescents (<18 years) with chronic diseases and assessed oral dietary supplements against placebo, standard care, or no intervention. Thirteen studies were included.</p><p><strong>Results: </strong>The studies investigated autism spectrum disorder (ASD), functional gastrointestinal disorders, cystic fibrosis (CF), type 1 diabetes (T1D), bronchopulmonary dysplasia (BPD) and juvenile idiopathic arthritis. Interventions included probiotics, omega-3/6 fatty acids, vitamins, minerals, glutathione, Kre-Celazine® and Dimercaptosuccinic Acid (DMSA). Most supplements demonstrated measurable bioactivity, such as modulation of the gut microbiota, changes in inflammatory markers, or improvements in functional indices, but clinical benefits were often inconsistent or limited to subgroups. Safety was generally favorable for probiotics, polyunsaturated fatty acids, magnesium, zinc, and vitamin A, whereas DMSA chelation raised significant safety concerns.</p><p><strong>Conclusions: </strong>Dietary and oral supplements show promise as supportive interventions in pediatric chronic diseases but cannot yet be recommended for systematic clinical use. Larger multicenter trials with longer follow-up, standardized endpoints, and predictive biomarkers are needed to identify responder subgroups and establish evidence-based recommendations.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1710200"},"PeriodicalIF":2.0,"publicationDate":"2026-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146085456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: This meta-analysis investigates the association between maternal anxiety/depression during pregnancy and the development of eczema/atopic dermatitis (AD) in offspring.
Methods: A literature search was conducted across four electronic databases (PubMed, Web of Science, Embase, and the Cochrane Library) for studies published from database inception until July 2025. In this study, maternal depression and anxiety were defined as conditions physician-diagnosed or assessed with standardized scales during pregnancy. The primary outcome was the incidence of eczema/AD in the offspring.
Result: A total of 12 cohort studies were included in this meta-analysis. Pooled results indicated that maternal depression [odds ratio (OR) = 1.06, 95% confidence interval (95% CI) = 1.01-1.11, p = 0.015] or anxiety (OR = 1.11, 95% CI = 1.03-1.19, p = 0.005) during pregnancy was potentially associated with a higher incidence of offspring eczema and AD. Subgroup analysis revealed that there was a higher incidence of AD in offspring with maternal anxiety during pregnancy (OR = 1.24, p = 0.028), while no significant difference was observed in the incidence of eczema (p = 0.286). A higher incidence of offspring eczema/AD was observed in offspring of both Eastern (OR = 1.13, p = 0.043) and Western (OR = 1.34, p = 0.049) countries. Moreover, the incidence was higher in offspring when maternal anxiety was identified in the first (OR = 1.13, p = 0.036) or second (OR = 1.25, p = 0.010) trimester, whereas no significant difference was found for exposure in the third trimester (p = 0.152). For maternal depression during pregnancy, offspring had a higher incidence of AD (OR = 1.17, p < 0.001), while no significant difference was observed for eczema (p = 0.145). Furthermore, the incidence of offspring eczema/AD was higher in Eastern countries (OR = 1.14, p = 0.035), while Western countries group showed no significant difference (p = 0.111). Additionally, when analyzed by timing of exposure, the incidence was higher when depression was identified in the second trimester (OR = 1.30, p = 0.027), with no significant difference found in the third trimester (p = 0.163).
Conclusion: This study suggests that maternal depression/anxiety during pregnancy is potentially associated with the development of eczema/AD in offspring.
背景:本荟萃分析调查了怀孕期间母亲焦虑/抑郁与后代湿疹/特应性皮炎(AD)发展之间的关系。方法:对四个电子数据库(PubMed、Web of Science、Embase和Cochrane Library)进行文献检索,检索从数据库建立到2025年7月发表的研究。在这项研究中,母亲的抑郁和焦虑被定义为在怀孕期间由医生诊断或用标准化量表评估的状况。主要结果是后代湿疹/AD的发病率。结果:本荟萃分析共纳入12项队列研究。综合结果显示,妊娠期母亲抑郁[比值比(OR) = 1.06, 95%可信区间(95% CI) = 1.01-1.11, p = 0.015]或焦虑(OR = 1.11, 95% CI = 1.03-1.19, p = 0.005)可能与后代湿疹和AD的高发病率相关。亚组分析显示,妊娠期母亲焦虑的后代AD发病率较高(OR = 1.24, p = 0.028),而湿疹发病率无显著差异(p = 0.286)。东方国家(OR = 1.13, p = 0.043)和西方国家(OR = 1.34, p = 0.049)的后代湿疹/AD发病率均较高。此外,在妊娠第一阶段(OR = 1.13, p = 0.036)或妊娠第二阶段(OR = 1.25, p = 0.010)发现母亲焦虑时,后代的发病率更高,而在妊娠第三阶段(p = 0.152)没有发现显着差异。母亲孕期抑郁,后代AD发病率较高(OR = 1.17, p = 0.145)。子代湿疹/AD的发生率东方国家较高(OR = 1.14, p = 0.035),而西方国家组差异无统计学意义(p = 0.111)。此外,当通过暴露时间分析时,在妊娠中期发现抑郁症时发病率更高(OR = 1.30, p = 0.027),而在妊娠晚期发现无显著差异(p = 0.163)。结论:本研究提示孕妇孕期抑郁/焦虑可能与后代湿疹/AD的发生有关。
{"title":"Association between maternal anxiety/depression in pregnancy and the development of offspring eczema/AD: a meta-analysis based on cohort studies.","authors":"Mengjiao Yu, Qiufeng Zhang, Junyi Chen, Jingyu Yang, Zhechuan Bai, Junjie Wang","doi":"10.3389/fped.2025.1734662","DOIUrl":"https://doi.org/10.3389/fped.2025.1734662","url":null,"abstract":"<p><strong>Background: </strong>This meta-analysis investigates the association between maternal anxiety/depression during pregnancy and the development of eczema/atopic dermatitis (AD) in offspring.</p><p><strong>Methods: </strong>A literature search was conducted across four electronic databases (PubMed, Web of Science, Embase, and the Cochrane Library) for studies published from database inception until July 2025. In this study, maternal depression and anxiety were defined as conditions physician-diagnosed or assessed with standardized scales during pregnancy. The primary outcome was the incidence of eczema/AD in the offspring.</p><p><strong>Result: </strong>A total of 12 cohort studies were included in this meta-analysis. Pooled results indicated that maternal depression [odds ratio (OR) = 1.06, 95% confidence interval (95% CI) = 1.01-1.11, <i>p</i> = 0.015] or anxiety (OR = 1.11, 95% CI = 1.03-1.19, <i>p</i> = 0.005) during pregnancy was potentially associated with a higher incidence of offspring eczema and AD. Subgroup analysis revealed that there was a higher incidence of AD in offspring with maternal anxiety during pregnancy (OR = 1.24, <i>p</i> = 0.028), while no significant difference was observed in the incidence of eczema (<i>p</i> = 0.286). A higher incidence of offspring eczema/AD was observed in offspring of both Eastern (OR = 1.13, <i>p</i> = 0.043) and Western (OR = 1.34, <i>p</i> = 0.049) countries. Moreover, the incidence was higher in offspring when maternal anxiety was identified in the first (OR = 1.13, <i>p</i> = 0.036) or second (OR = 1.25, <i>p</i> = 0.010) trimester, whereas no significant difference was found for exposure in the third trimester (<i>p</i> = 0.152). For maternal depression during pregnancy, offspring had a higher incidence of AD (OR = 1.17, <i>p</i> < 0.001), while no significant difference was observed for eczema (<i>p</i> = 0.145). Furthermore, the incidence of offspring eczema/AD was higher in Eastern countries (OR = 1.14, <i>p</i> = 0.035), while Western countries group showed no significant difference (<i>p</i> = 0.111). Additionally, when analyzed by timing of exposure, the incidence was higher when depression was identified in the second trimester (OR = 1.30, <i>p</i> = 0.027), with no significant difference found in the third trimester (<i>p</i> = 0.163).</p><p><strong>Conclusion: </strong>This study suggests that maternal depression/anxiety during pregnancy is potentially associated with the development of eczema/AD in offspring.</p>","PeriodicalId":12637,"journal":{"name":"Frontiers in Pediatrics","volume":"13 ","pages":"1734662"},"PeriodicalIF":2.0,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12835386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}